Aegera Therapeutics
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
451 Smyth Rd Rm 3129, Ottawa, Ontario, K...Phone Number
(514) 288-5532Website
www.aegera.comRevenue
$6.3 MillionIndustry
About Aegera Therapeutics
Aegera Therapeutics Org Chart
Is Aegera Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Aegera Therapeutics had a recent Job posting/layoffs
Aegera Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if Aegera Therapeutics is spiking on competitors!
Check if Aegera Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Aegera Therapeutics
Funding: Get notified immidiatlly once Aegera Therapeutics has new funding data
Earning: See what the market has to say on Aegera Therapeutics recently announced quarterly report
Product Launch: Get notified when Aegera Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Aegera Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Aegera Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Aegera Therapeutics.
Aegera Therapeutics Tech Stack
A closer look at the technologies used by Aegera Therapeutics
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Aegera Therapeutics
Aegera Therapeutics is a well-funded, clinical-stage, Canadian biotechnology company focused on developing drugs that control apoptosis to address major, unmet medical needs. Aegera has four programs in clinical development for oncology and pain, including AEG35156, a second-generation antisense compound that targets the knockdown of XIAP, a key in... Read More